Acid lock may beat line infections in cancer patients
NCT ID NCT05376566
First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study tested whether a hydrochloric acid lock therapy (HALT) can reduce treatment failure for central line-associated bloodstream infections (CLABSI) in patients with cancer or blood disorders. 212 patients received either HALT or a placebo alongside standard antibiotics. The goal was to see if HALT lowers the risk of persistent infection, relapse, or infection-related complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTION (CLABSI) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Haematology, Copenhagen University Hospital
Copenhagen, 2100, Denmark
-
Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital
Aarhus, 3200, Denmark
-
Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital
Copenhagen, 2100, Denmark
-
Department of Paediatrics and Adolescent Medicine, Odense University Hospital
Odense, 4000, Denmark
Conditions
Explore the condition pages connected to this study.